Isolation and purification of STEAP1 protein fragment in Escherichia coli cells: a potential target for prostate cancer

Detalhes bibliográficos
Autor(a) principal: Ferreira, Jorge Daniel Barroca
Data de Publicação: 2016
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.6/5817
Resumo: Prostate cancer is the second most prevalent type of cancer worldwide and the sixth cancer-related death. The current applied therapies in advanced cancer stages are limited and not completely efficient. Thus, it is necessary to develop alternatives using, for example, molecular biology vanguard technologies that allow to identify genes that encode transmembrane proteins, abundantly expressed in cancer tissues. The six-transmembrane epithelial antigen of the prostate (STEAP1) was recognized as a protein presenting a structure with six transmembrane domains connected by extracellular loops. It is commonly located in plasma membrane, for example in communication junctions or even in endosomal membranes, suggesting a role as ion channel or transporter protein in intracellular communication between tumor cells. In association with its high specificity and significant expression levels in prostatic cancer tissues, STEAP1 is a promising candidate to be imposed as a therapeutic target, especially for immunotherapy. However, the impossibility of large-scale production hinders the development of structural and biointeraction studies, not only to establish the tridimensional structure of STEAP1 but also to understand its vivo behavior. Therefore, the main objectives consisted in establish the culture medium formulation and optimal fermentation conditions in order to achieve a maximum yield for the STEAP1 first loop (STEAP11-142) biosynthesis, besides access several conditions inherent to immobilized metal affinity chromatography (IMAC) to obtain considerable levels of purified peptide. The main results showed that TB medium fermentation at 37 ºC, 250 rpm and pH 7.2 over 8 hours increased the STEAP11-142 biosynthesis levels. Moreover, Triton X-100 at 1 % (v/v) demonstrated to be the most effective detergent for protein recovery. This result was validated by Western-blotting analysis which revealed a single immunoreactive band with the expected molecular weight (17-25 kDa). Concerning the purification step by IMAC, we tested two resins charged with nickel and cobalt. The results lead to a typical chromatographic profile where the target fragment was completed retained. Nevertheless, a considerable amount of heterologous proteins from Escherichia coli (E. coli) host co-eluted with the STEAP11-142 fragment, being necessary to develop an alternative elution strategy and optimize the purity of the target fractions.
id RCAP_497fc940d3e8f92f78af4d2dc11ff167
oai_identifier_str oai:ubibliorum.ubi.pt:10400.6/5817
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Isolation and purification of STEAP1 protein fragment in Escherichia coli cells: a potential target for prostate cancerCancro da PróstataImac.Produção de ProteínasProteínas MembranaresSteap1Domínio/Área Científica::Ciências Médicas::Ciências BiomédicasProstate cancer is the second most prevalent type of cancer worldwide and the sixth cancer-related death. The current applied therapies in advanced cancer stages are limited and not completely efficient. Thus, it is necessary to develop alternatives using, for example, molecular biology vanguard technologies that allow to identify genes that encode transmembrane proteins, abundantly expressed in cancer tissues. The six-transmembrane epithelial antigen of the prostate (STEAP1) was recognized as a protein presenting a structure with six transmembrane domains connected by extracellular loops. It is commonly located in plasma membrane, for example in communication junctions or even in endosomal membranes, suggesting a role as ion channel or transporter protein in intracellular communication between tumor cells. In association with its high specificity and significant expression levels in prostatic cancer tissues, STEAP1 is a promising candidate to be imposed as a therapeutic target, especially for immunotherapy. However, the impossibility of large-scale production hinders the development of structural and biointeraction studies, not only to establish the tridimensional structure of STEAP1 but also to understand its vivo behavior. Therefore, the main objectives consisted in establish the culture medium formulation and optimal fermentation conditions in order to achieve a maximum yield for the STEAP1 first loop (STEAP11-142) biosynthesis, besides access several conditions inherent to immobilized metal affinity chromatography (IMAC) to obtain considerable levels of purified peptide. The main results showed that TB medium fermentation at 37 ºC, 250 rpm and pH 7.2 over 8 hours increased the STEAP11-142 biosynthesis levels. Moreover, Triton X-100 at 1 % (v/v) demonstrated to be the most effective detergent for protein recovery. This result was validated by Western-blotting analysis which revealed a single immunoreactive band with the expected molecular weight (17-25 kDa). Concerning the purification step by IMAC, we tested two resins charged with nickel and cobalt. The results lead to a typical chromatographic profile where the target fragment was completed retained. Nevertheless, a considerable amount of heterologous proteins from Escherichia coli (E. coli) host co-eluted with the STEAP11-142 fragment, being necessary to develop an alternative elution strategy and optimize the purity of the target fractions.O cancro da próstata é o segundo tipo de cancro mais prevalente em todo mundo e a sexta causa de morte relacionada com a doença. As terapias atualmente aplicadas nomeadamente em estádios avançados não são completamente eficazes e apresentam diversas limitações. Por conseguinte, é necessário desenvolver alternativas recorrendo, por exemplo, a tecnologias vanguardistas que permitam identificar genes codificantes de proteínas membranares, abundantemente expressas em tecidos cancerígenos. The six-transmembrane epithelial antigen of the prostate 1 (STEAP1) é uma proteína constituída por seis domínios transmembranares interligados por loops extracelulares, geralmente localizada na membrana plasmática, como por exemplo em junções de comunicação ou mesmo em membranas endossomais, sugerindo que atua como um canal membranar ou proteína transportadora ao nível da comunicação intercelular entre células tumorais. Em associação com a elevada especificidade e níveis de expressão significativos em tecidos cancerígenos prostáticos, a STEAP1 é um candidato promissor para ser imposto como alvo terapêutico, em especial para imunoterapia. No entanto, o facto de não ser possível a sua produção em quantidades significativas impede o desenvolvimento de estudos que permitam estabelecer a estrutura tridimensional e estudar o seu comportamento in vivo. Assim, os objetivos principais consistiram em definir o meio de cultura e as condições ótimas de fermentação para obter o máximo de rentabilidade na biossíntese do primeiro loop da STEAP1 (STEAP11-142), para além de avaliar diferentes condições inerentes ao método immobilized metal affinity chromatography (IMAC), de forma a obter níveis consideráveis de péptido purificado. Os resultados demonstraram que a fermentação em meio TB a 37 ºC, 250 rpm e pH 7.2 ao longo de 8 horas aumentou os níveis de biossíntese de STEAP11-142. O detergente Triton X-100 a 1 % (v/v) provou ser o mais eficaz ao nível da recuperação proteica, resultado validado por Western-blot pela presença de uma banda única imunorreativa com o peso molecular expectável (17-25 kDa). No passo de purificação foram testadas duas resinas carregadas com níquel e cobalto. Os resultados evidenciaram um típico perfil cromatográfico, no qual a proteína alvo foi completamente retida. No entanto, uma quantidade considerável de proteínas provenientes do hospedeiro Escherichia coli (E. coli) eluíram juntamente com o fragmento STEAP11-142, sendo necessário desenvolver uma estratégia alternativa de eluição e otimizar a pureza das frações alvo.Batista, Cláudio Jorge MaiaPassarinha, Luís António PaulinouBibliorumFerreira, Jorge Daniel Barroca2018-08-28T15:55:55Z2016-6-62016-06-282016-06-28T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10400.6/5817TID:201771420enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-12-15T09:43:59Zoai:ubibliorum.ubi.pt:10400.6/5817Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:46:39.209223Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Isolation and purification of STEAP1 protein fragment in Escherichia coli cells: a potential target for prostate cancer
title Isolation and purification of STEAP1 protein fragment in Escherichia coli cells: a potential target for prostate cancer
spellingShingle Isolation and purification of STEAP1 protein fragment in Escherichia coli cells: a potential target for prostate cancer
Ferreira, Jorge Daniel Barroca
Cancro da Próstata
Imac.
Produção de Proteínas
Proteínas Membranares
Steap1
Domínio/Área Científica::Ciências Médicas::Ciências Biomédicas
title_short Isolation and purification of STEAP1 protein fragment in Escherichia coli cells: a potential target for prostate cancer
title_full Isolation and purification of STEAP1 protein fragment in Escherichia coli cells: a potential target for prostate cancer
title_fullStr Isolation and purification of STEAP1 protein fragment in Escherichia coli cells: a potential target for prostate cancer
title_full_unstemmed Isolation and purification of STEAP1 protein fragment in Escherichia coli cells: a potential target for prostate cancer
title_sort Isolation and purification of STEAP1 protein fragment in Escherichia coli cells: a potential target for prostate cancer
author Ferreira, Jorge Daniel Barroca
author_facet Ferreira, Jorge Daniel Barroca
author_role author
dc.contributor.none.fl_str_mv Batista, Cláudio Jorge Maia
Passarinha, Luís António Paulino
uBibliorum
dc.contributor.author.fl_str_mv Ferreira, Jorge Daniel Barroca
dc.subject.por.fl_str_mv Cancro da Próstata
Imac.
Produção de Proteínas
Proteínas Membranares
Steap1
Domínio/Área Científica::Ciências Médicas::Ciências Biomédicas
topic Cancro da Próstata
Imac.
Produção de Proteínas
Proteínas Membranares
Steap1
Domínio/Área Científica::Ciências Médicas::Ciências Biomédicas
description Prostate cancer is the second most prevalent type of cancer worldwide and the sixth cancer-related death. The current applied therapies in advanced cancer stages are limited and not completely efficient. Thus, it is necessary to develop alternatives using, for example, molecular biology vanguard technologies that allow to identify genes that encode transmembrane proteins, abundantly expressed in cancer tissues. The six-transmembrane epithelial antigen of the prostate (STEAP1) was recognized as a protein presenting a structure with six transmembrane domains connected by extracellular loops. It is commonly located in plasma membrane, for example in communication junctions or even in endosomal membranes, suggesting a role as ion channel or transporter protein in intracellular communication between tumor cells. In association with its high specificity and significant expression levels in prostatic cancer tissues, STEAP1 is a promising candidate to be imposed as a therapeutic target, especially for immunotherapy. However, the impossibility of large-scale production hinders the development of structural and biointeraction studies, not only to establish the tridimensional structure of STEAP1 but also to understand its vivo behavior. Therefore, the main objectives consisted in establish the culture medium formulation and optimal fermentation conditions in order to achieve a maximum yield for the STEAP1 first loop (STEAP11-142) biosynthesis, besides access several conditions inherent to immobilized metal affinity chromatography (IMAC) to obtain considerable levels of purified peptide. The main results showed that TB medium fermentation at 37 ºC, 250 rpm and pH 7.2 over 8 hours increased the STEAP11-142 biosynthesis levels. Moreover, Triton X-100 at 1 % (v/v) demonstrated to be the most effective detergent for protein recovery. This result was validated by Western-blotting analysis which revealed a single immunoreactive band with the expected molecular weight (17-25 kDa). Concerning the purification step by IMAC, we tested two resins charged with nickel and cobalt. The results lead to a typical chromatographic profile where the target fragment was completed retained. Nevertheless, a considerable amount of heterologous proteins from Escherichia coli (E. coli) host co-eluted with the STEAP11-142 fragment, being necessary to develop an alternative elution strategy and optimize the purity of the target fractions.
publishDate 2016
dc.date.none.fl_str_mv 2016-6-6
2016-06-28
2016-06-28T00:00:00Z
2018-08-28T15:55:55Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.6/5817
TID:201771420
url http://hdl.handle.net/10400.6/5817
identifier_str_mv TID:201771420
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136362718298112